AusperBio Secures $120 Million Series C Funding for Hepatitis B Therapy Development
Biotechnology firm AusperBio has successfully closed a $120 million Series C financing round to advance its experimental hepatitis B treatment, AHB-137. The capital will support clinical development and potential commercialization efforts for the next-generation antiviral drug.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (27/100)Sources
AusperBio Completes $120 Million Series C Financing to Advance AHB-137 Toward Potential Commercialization and Expand Next-Generation HBV Therapies - Morningstar
AusperBio Completes $120 Million Series C Financing to Advance AHB-137 Toward Potential Commercialization and Expand Next-Generation HBV Therapies Morningstar
Read full article →A social media app that feels like the old Instagram days raised $21 million
Retro is a social media app for sharing content with friends and family. Screenshot/Retro/BI Retro, designed by ex-Instagram employees, is a social app for sharing content with close friends. The startup behind it has raised $21 million, recent financial filings reveal. It's one of many new social media apps taking on Big Tech platforms. There's a social media app I like using more than Instagram or TikTok — and it's attracted serious investor interest. The app, called Retro, is an Instagra...
Read full article →Coverage Timeline
Related Stories
Airbus Seeks Sale of U.S. Space Unit to Bolster European Satellite Alliance
20m ago
Fed Chair Warsh Signals Potential Rate Hikes Amid Stubborn Inflation
1h ago
Temasek Backs Singapore Airlines’ Investment in Air India Amid Scrutiny
1h ago
Dolly Parton’s Business Strategy and Cultural Legacy Examined
2h ago